Singapore markets closed

LLY Jul 2024 740.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.0300-0.0900 (-75.00%)
As of 12:34PM EDT. Market open.
Full screen
Loading interactive chart…
  • Zacks

    Time for Healthcare ETFs?

    Compelling valuation, innovation in specific growth areas and an aging population as well as increasing healthcare spending are the tailwinds of the medical sector.

  • Zacks

    Eli Lilly (LLY) Advances But Underperforms Market: Key Facts

    In the most recent trading session, Eli Lilly (LLY) closed at $865.97, indicating a +0.99% shift from the previous trading day.

  • Benzinga

    AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst

    HC Wainwright analyst initiated coverage on AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering immunology therapeutics. AnaptysBio has a pipeline of checkpoint agonists, including rosnilimab, a PD-1 agonist in development for rheumatoid arthritis (RA) and ulcerative colitis (UC), and ANB032, a B and T cell lymphocyte attenuator (BTLA) agonist in development for atopic dermatitis (AD). In Phase 1, rosnilimab showed a 90% reduction of T cell proliferation, i